Truvada Emtricitabine/Tenofovir 200mg/300mg | Gilead USA Originator | GLT

Generic Information: Truvada (United States)

Truvada is the originator fixed-dose combination of emtricitabine and tenofovir disoproxil fumarate, developed and marketed by Gilead Sciences. This United States presentation supplies each film-coated tablet with 200 mg of emtricitabine and 300 mg of tenofovir disoproxil fumarate, thirty tablets per bottle. Truvada was the first medicine ever approved to lower the risk of sexually acquired HIV-1, and it remains a backbone of both treatment and prevention regimens around the world.

What Is Emtricitabine/Tenofovir (Truvada) Used For?

The combination has two licensed roles. In treatment, it is given together with other antiretroviral agents to suppress HIV-1 in adults and adolescents who weigh at least 35 kg. In prevention, it is taken as pre-exposure prophylaxis, or PrEP, to reduce the chance of acquiring HIV-1 through sex in people who test HIV-negative. The two uses share the same tablet but carry different safety rules — PrEP requires confirmed negative status before starting and periodic retesting during use.

How Does Emtricitabine/Tenofovir Work?

Both ingredients are reverse transcriptase inhibitors that stop the virus at the same step but through two related chemistries. Emtricitabine is a nucleoside analogue of cytidine, while tenofovir is a nucleotide analogue of adenosine monophosphate; once activated inside cells, each mimics a natural building block and is mistaken by HIV's reverse transcriptase, terminating the growing viral DNA chain. Together they provide a durable two-drug barrier that is hard for the virus to overcome when adherence is good.

Indications

Truvada is indicated, in combination with other antiretrovirals, for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg. It is separately indicated for HIV-1 pre-exposure prophylaxis in at-risk adults and adolescents weighing at least 35 kg, to reduce the risk of sexually acquired HIV-1. It is not a treatment for hepatitis B, and stopping it in someone co-infected with HBV can trigger a flare, so liver status is checked before use.

Dosage

The standard dose for both treatment and PrEP is one tablet — 200 mg emtricitabine plus 300 mg tenofovir disoproxil fumarate — taken once daily with or without food. For people with reduced kidney function the interval is lengthened, and the medicine is not recommended below certain creatinine-clearance thresholds. Anyone taking it for PrEP must have a documented negative HIV test before starting and be retested on a regular schedule, because using PrEP while already infected can encourage resistance.

Side Effects

Common effects include nausea, diarrhea, headache, dizziness and fatigue, most of which ease as the body adjusts. The important long-term concerns are kidney injury and loss of bone mineral density, both linked to the tenofovir disoproxil component, so renal function is monitored and bone health is considered in at-risk patients. Rare but serious warnings cover lactic acidosis with liver enlargement and severe flare of hepatitis B if the drug is stopped in co-infected patients.

Storage

Truvada is stored at room temperature in its original bottle with the cap tightly closed, away from moisture and heat. No refrigeration is needed, so the tablets travel reliably by ambient-condition courier. GLT ships from a Hong Kong-licensed facility with batch documentation and a certificate of analysis enclosed.

Why Choose Truvada Through GLT?

The United States presentation carries Gilead's reference-standard provenance for institutions and importing pharmacies that require the originator product. Its dual treatment-and-prevention indication makes it a versatile single-tablet backbone for HIV programs. GLT's Hong Kong base supports documented cross-border supply and traceable sourcing for overseas buyers.

How to Order

To order Truvada (emtricitabine/tenofovir disoproxil fumarate) from GLT, contact us on WhatsApp at +86 15234153837 or by email at [email protected]. We confirm stock, pack options and delivery timelines to your country, and dispatch from a Hong Kong-licensed facility.

FAQ

Is Truvada the original emtricitabine/tenofovir? Yes — Truvada is Gilead's originator brand, first approved in 2004 and still the reference fixed-dose combination.

Can Truvada both treat and prevent HIV? Yes. It treats HIV-1 in combination with other drugs, and as PrEP it lowers the risk of sexually acquired HIV-1 in people who test negative.

Do I need kidney monitoring? Yes — the tenofovir disoproxil component can affect the kidneys and bone, so renal function is checked regularly.